{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T09:28:56Z","timestamp":1792056536261,"version":"4.4.0"},"publisher-location":"Cham","reference-count":73,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783031280115","type":"print"},{"value":"9783031280122","type":"electronic"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1007\/978-3-031-28012-2_21","type":"book-chapter","created":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T12:02:41Z","timestamp":1687953761000},"page":"397-411","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Antiviral Mechanisms of Curcumin and Its Derivatives in Prevention and Treatment of COVID-19: A Review"],"prefix":"10.1007","author":[{"given":"Sahar","family":"Golpour-Hamedani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makan","family":"Pourmasoumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gholamreza","family":"Askari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Bagherniya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammed","family":"Majeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul C.","family":"Guest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Sahebkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,29]]},"reference":[{"issue":"4\u20135","key":"21_CR1","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.micinf.2020.04.009","volume":"22","author":"MA Moreno-Eutimio","year":"2020","unstructured":"Moreno-Eutimio MA, Lopez-Macias C, Pastelin-Palacios R (2020) Bioinformatic analysis and identification of single-stranded RNA sequences recognized by TLR7\/8 in the SARS-CoV-2, SARS-CoV, and MERS-CoV genomes. Microbes Infect 22(4\u20135):226\u2013229","journal-title":"Microbes Infect"},{"issue":"3","key":"21_CR2","doi-asserted-by":"publisher","first-page":"105924","DOI":"10.1016\/j.ijantimicag.2020.105924","volume":"55","author":"CC Lai","year":"2020","unstructured":"Lai CC, Shih TP, Ko WC, et al (2020) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents 55(3):105924. https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105924","journal-title":"Int J Antimicrob Agents"},{"key":"21_CR3","doi-asserted-by":"publisher","unstructured":"Gorbalenya AE, Baker SC, Baric RS, et al (2020) Severe acute respiratory syndrome-related coronavirus: The species and its viruses\u2013a statement of the Coronavirus Study Group. BioRxiv. https:\/\/doi.org\/10.1038\/s41564-020-0695-z","DOI":"10.1038\/s41564-020-0695-z"},{"issue":"3","key":"21_CR4","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","volume":"30","author":"M Wang","year":"2020","unstructured":"Wang M, Cao R, Zhang L, et al (2020) Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res 30(3):269\u2013271","journal-title":"Cell Res"},{"issue":"18","key":"21_CR5","doi-asserted-by":"publisher","first-page":"11555","DOI":"10.1128\/JVI.79.18.11555-11558.2005","volume":"79","author":"SF Elena","year":"2005","unstructured":"Elena SF, Sanju\u00e1n R (2005) Adaptive value of high mutation rates of RNA viruses: separating causes from consequences. J Virol 79(18):11555\u201311558","journal-title":"J Virol"},{"issue":"18","key":"21_CR6","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","volume":"382","author":"WJ Guan","year":"2020","unstructured":"Guan WJ, Ni ZY, Hu Y, et al (2020) Clinical characteristics of coronavirus disease 2019 in China. New Engl J Med 382(18):1708\u20131720","journal-title":"New Engl J Med"},{"issue":"1","key":"21_CR7","first-page":"1","volume":"7","author":"YR Guo","year":"2020","unstructured":"Guo YR, Cao QD, Hong ZS, et al (2020) The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak\u2013an update on the status. Mil Med Res 7(1):1\u201310","journal-title":"Mil Med Res"},{"issue":"2","key":"21_CR8","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.micinf.2020.02.002","volume":"22","author":"JY Li","year":"2020","unstructured":"Li JY, You Z, Wang Q, et al (2020) The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future. Microbes Infect 22(2):80\u201385","journal-title":"Microbes Infect"},{"issue":"09","key":"21_CR9","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1097\/CM9.0000000000000744","volume":"133","author":"K Liu","year":"2020","unstructured":"Liu K, Fang YY, Deng Y, et al (2020) Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chinese Med J 133(09):1025\u20131031","journal-title":"Chinese Med J"},{"issue":"10223","key":"21_CR10","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395(10223):497\u2013506","journal-title":"Lancet"},{"key":"21_CR11","unstructured":"European Medicines Agency; COVID-19 Treatments; Approved for use in the European Union (2022). https:\/\/www.ema.europa.eu\/en\/human-regulatory\/overview\/public-health-threats\/coronavirus-disease-covid-19\/treatments-vaccines\/covid-19-treatments. Accessed October 24, 2022"},{"issue":"6","key":"21_CR12","first-page":"1192","volume":"17","author":"A Sahebkar","year":"2016","unstructured":"Sahebkar A, Henrotin Y (2016) Analgesic efficacy and safety of curcuminoids in clinical practice: a systematic review and meta-analysis of randomized controlled trials. Pain Med 17(6):1192\u20131202","journal-title":"Pain Med"},{"key":"21_CR13","doi-asserted-by":"publisher","unstructured":"Praditya D, Kirchhoff L, Br\u00fcning J et al (2019) Anti-infective properties of the golden spice curcumin. Front Microbiol 10912. https:\/\/doi.org\/10.3389\/fmicb.2019.00912","DOI":"10.3389\/fmicb.2019.00912"},{"issue":"11","key":"21_CR14","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1080\/01483918808067200","volume":"11","author":"A Khurana","year":"1988","unstructured":"Khurana A, Ho CT (1988) High performance liquid chromatographic analysis of curcuminoids and their photo-oxidative decomposition compounds in Curcuma longa L. J Liq Chromatogr 11(11):2295\u20132304","journal-title":"J Liq Chromatogr"},{"issue":"2","key":"21_CR15","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.autrev.2017.11.016","volume":"17","author":"AA Momtazi-Borojeni","year":"2018","unstructured":"Momtazi-Borojeni AA, Haftcheshmeh SM, Esmaeili SA, et al (2018) Curcumin: A natural modulator of immune cells in systemic lupus erythematosus. Autoimmun Rev 17(2):125\u2013135","journal-title":"Autoimmun Rev"},{"key":"21_CR16","doi-asserted-by":"crossref","unstructured":"Hasanzadeh S, Read MI, Bland AR, et al (2020) Curcumin: an inflammasome silencer. Pharmacol Res 159:104921","DOI":"10.1016\/j.phrs.2020.104921"},{"issue":"5","key":"21_CR17","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1097\/CEJ.0b013e32832c389e","volume":"18","author":"M Iranshahi","year":"2009","unstructured":"Iranshahi M, Sahebkar A, Takasaki M, et al (2009) Cancer chemopreventive activity of the prenylated coumarin, umbelliprenin, in vivo. Eur J Cancer Prev 18(5):412\u2013415","journal-title":"Eur J Cancer Prev"},{"issue":"11","key":"21_CR18","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1055\/s-0034-1389986","volume":"65","author":"Y Panahi","year":"2014","unstructured":"Panahi Y, Ghanei M, Bashiri S, et al (2014) Short-term Curcuminoid Supplementation for Chronic Pulmonary Complications due to Sulfur Mustard Intoxication: Positive Results of a Randomized Double-blind Placebo-controlled Trial. Drug Res 65(11):567\u2013573","journal-title":"Drug Res"},{"key":"21_CR19","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.phrs.2018.09.012","volume":"136","author":"N Parsamanesh","year":"2018","unstructured":"Parsamanesh N, Moossavi M, Bahrami A, et al (2018) Therapeutic potential of curcumin in diabetic complications. Pharmacol Res 136:181\u2013193","journal-title":"Pharmacol Res"},{"issue":"5","key":"21_CR20","doi-asserted-by":"publisher","first-page":"e75","DOI":"10.1016\/j.fertnstert.2010.07.1071","volume":"94","author":"A Sahebkar","year":"2010","unstructured":"Sahebkar A (2010) Molecular mechanisms for curcumin benefits against ischemic injury. Fertil Steril 94(5):e75\u2013e76","journal-title":"Fertil Steril"},{"issue":"5","key":"21_CR21","doi-asserted-by":"publisher","first-page":"5643","DOI":"10.1002\/jcp.27404","volume":"234","author":"A Shakeri","year":"2019","unstructured":"Shakeri A, Cicero AFG, Panahi Y, et al (2019) Curcumin: A naturally occurring autophagy modulator. J Cell Physiol 234(5):5643\u20135654","journal-title":"J Cell Physiol"},{"issue":"39","key":"21_CR22","doi-asserted-by":"publisher","first-page":"8116","DOI":"10.2174\/0929867327666201111145212","volume":"28","author":"AR Afshari","year":"2021","unstructured":"Afshari AR, Jalili-Nik M, Abbasinezhad-Moud F, et al (2021) Anti-tumor effects of curcuminoids in glioblastoma multiforme: An updated literature review. Curr Med Chem 28(39):8116\u20138138","journal-title":"Curr Med Chem"},{"key":"21_CR23","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.tifs.2020.03.026","volume":"99","author":"M Alidadi","year":"2020","unstructured":"Alidadi M, Jamialahmadi T, Cicero AFG, et al (2020) The potential role of plant-derived natural products in improving arterial stiffness: A review of dietary intervention studies. Trends Food Sci Technol 99:426\u2013440","journal-title":"Trends Food Sci Technol"},{"issue":"22","key":"21_CR24","doi-asserted-by":"publisher","first-page":"4029","DOI":"10.3390\/molecules24224029","volume":"24","author":"AM Gorabi","year":"2019","unstructured":"Gorabi AM, Kiaie N, Hajighasemi S, et al (2019) The effect of curcumin on the differentiation of mesenchymal stem cells into mesodermal lineage. Molecules 24(22):4029. https:\/\/doi.org\/10.3390\/molecules24224029","journal-title":"Molecules"},{"key":"21_CR25","doi-asserted-by":"publisher","first-page":"104765","DOI":"10.1016\/j.phrs.2020.104765","volume":"156","author":"M Mohajeri","year":"2020","unstructured":"Mohajeri M, Bianconi V, \u00c1vila-Rodriguez MF, et al (2020) Curcumin: a phytochemical modulator of estrogens and androgens in tumors of the reproductive system. Pharmacological Research 156:104765. https:\/\/doi.org\/10.1016\/j.phrs.2020.104765","journal-title":"Pharmacological Research"},{"issue":"4","key":"21_CR26","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1002\/ptr.7350","volume":"36","author":"Z Heidari","year":"2022","unstructured":"Heidari Z, Daei M, Boozari M, et al (2022) Curcumin supplementation in pediatric patients: A systematic review of current clinical evidence. Phytother Res 36(4):1442\u20131458","journal-title":"Phytother Res"},{"issue":"5","key":"21_CR27","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.ctim.2014.07.006","volume":"22","author":"Y Panahi","year":"2014","unstructured":"Panahi Y, Khalili N, Hosseini MS, et al (2014) Lipid-modifying effects of adjunctive therapy with curcuminoids-piperine combination in patients with metabolic syndrome: Results of a randomized controlled trial. Complement Ther Med 22(5):851\u2013857","journal-title":"Complement Ther Med"},{"issue":"8","key":"21_CR28","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1002\/ijc.24547","volume":"125","author":"BT Kurien","year":"2009","unstructured":"Kurien BT,Scofield RH (2009) Oral dministration of heat-solubilized curcumin for potentially increasing curcumin bioavailability in experimental animals. Int J Cancer 125(8):1992. https:\/\/doi.org\/10.1002\/ijc.24547","journal-title":"Int J Cancer"},{"issue":"8","key":"21_CR29","doi-asserted-by":"publisher","first-page":"3228","DOI":"10.1073\/pnas.91.8.3228","volume":"91","author":"JL Masferrer","year":"1994","unstructured":"Masferrer JL, Zweifel BS, Manning PT, et al (1994) Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic. Proc Nat Acad Sci USA 91(8):3228\u20133232","journal-title":"Proc Nat Acad Sci USA"},{"key":"21_CR30","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S0027-5107(01)00183-X","volume":"480\u2013481","author":"YJ Surh","year":"2001","unstructured":"Surh YJ, Chun KS, Cha HH, et al (2001) Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-\u03baB activation. Mutat Res 480\u2013481:243\u2013268","journal-title":"Mutat Res"},{"issue":"6","key":"21_CR31","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S0968-0896(00)82152-5","volume":"1","author":"Z Sui","year":"1993","unstructured":"Sui Z, Salto R, Li J, et al (1993) Inhibition of the HIV-1 and HIV-2 proteases by curcumin and curcumin boron complexes. Bioorg Med Chem 1(6):415\u2013422","journal-title":"Bioorg Med Chem"},{"issue":"11","key":"21_CR32","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1002\/ptr.6738","volume":"34","author":"F Zahedipour","year":"2020","unstructured":"Zahedipour F, Hosseini SA, Sathyapalan T, et al (2020) Potential effects of curcumin in the treatment of COVID-19 infection. Phytother Res 34(11):2911\u20132920","journal-title":"Phytother Res"},{"issue":"2","key":"21_CR33","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3390\/nu14020256","volume":"14","author":"A Vahedian-Azimi","year":"2022","unstructured":"Vahedian-Azimi A, Abbasifard M, Rahimi-Bashar F, et al (2022) Effectiveness of curcumin on outcomes of hospitalized COVID-19 patients: A systematic review of clinical trials. Nutrients 14(2):256. https:\/\/doi.org\/10.3390\/nu14020256","journal-title":"Nutrients"},{"key":"21_CR34","doi-asserted-by":"publisher","first-page":"671498","DOI":"10.3389\/fphar.2021.671498","volume":"12","author":"S Alam","year":"2021","unstructured":"Alam S, Sarker MMR, Afrin S, et al (2021) Traditional herbal medicines, bioactive metabolites, and plant products against COVID-19: update on clinical trials and mechanism of actions. Front Pharmacol 12:671498. https:\/\/doi.org\/10.3389\/fphar.2021.671498","journal-title":"Front Pharmacol"},{"issue":"1","key":"21_CR35","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.cbi.2004.09.013","volume":"150","author":"Y Yang","year":"2004","unstructured":"Yang Y, Blomme EA, Waring JF (2004) Toxicogenomics in drug discovery: from preclinical studies to clinical trials. Chem Biol Interact 150(1):71\u201385","journal-title":"Chem Biol Interact"},{"key":"21_CR36","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-4939-6730-8_1","volume":"1546","author":"H Rahmoune","year":"2017","unstructured":"Rahmoune H, Guest PC (2017) Application of multiplex biomarker approaches to accelerate drug discovery and development. Methods Mol Biol 1546:3\u201317","journal-title":"Methods Mol Biol"},{"key":"21_CR37","doi-asserted-by":"publisher","first-page":"100373","DOI":"10.1016\/j.dmpk.2020.11.008","volume":"37","author":"D Saigusa","year":"2021","unstructured":"Saigusa D, Matsukawa N, Hishinuma E, et al (2021) Identification of biomarkers to diagnose diseases and find adverse drug reactions by metabolomics. Drug Metab Pharmacokinet 37:100373. https:\/\/doi.org\/10.1016\/j.dmpk.2020.11.008","journal-title":"Drug Metab Pharmacokinet"},{"key":"21_CR38","series-title":"Methods in Molecular Biology","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-0716-2395-4","volume-title":"Multiplex Biomarker Techniques: Methods and Applications for COVID-19 Disease Diagnosis and Risk Stratification","author":"PC Guest","year":"2022","unstructured":"Guest PC (2022) Multiplex Biomarker Techniques: Methods and Applications for COVID-19 Disease Diagnosis and Risk Stratification; Methods in Molecular Biology, 251; Humana Press; Totowa, NJ, USA. ISBN-13: 978-1071623947"},{"issue":"2","key":"21_CR39","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S, et al (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181(2):271\u2013280.e278","journal-title":"Cell"},{"issue":"21","key":"21_CR40","doi-asserted-by":"publisher","first-page":"11727","DOI":"10.1073\/pnas.2003138117","volume":"117","author":"J Shang","year":"2020","unstructured":"Shang J, Wan Y, Luo C, et al (2020) Cell entry mechanisms of SARS-CoV-2. Proc Nat Acad Sci USA 117(21):11727\u201311734","journal-title":"Proc Nat Acad Sci USA"},{"issue":"2","key":"21_CR41","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s13337-020-00598-8","volume":"31","author":"VK Maurya","year":"2020","unstructured":"Maurya VK, Kumar S, Prasad AK, et al (2020) Structure-based drug designing for potential antiviral activity of selected natural products from Ayurveda against SARS-CoV-2 spike glycoprotein and its cellular receptor. Virusdisease 31(2):179\u2013193","journal-title":"Virusdisease"},{"issue":"19","key":"21_CR42","doi-asserted-by":"publisher","first-page":"4891","DOI":"10.3390\/ijms20194891","volume":"20","author":"S Katta","year":"2019","unstructured":"Katta S, Srivastava A, Thangapazham RL, et al (2019) Curcumin-gene expression response in hormone dependent and independent metastatic prostate cancer cells. Int J Mol Sci 20(19):4891. https:\/\/doi.org\/10.3390\/ijms20194891","journal-title":"Int J Mol Sci"},{"key":"21_CR43","doi-asserted-by":"publisher","unstructured":"Suravajhala R, Parashar A, Malik B, et al (2020) Comparative docking studies on curcumin with COVID-19 proteins. Preprints 2020050439. https:\/\/doi.org\/10.20944\/preprints202005.0439.v3","DOI":"10.20944\/preprints202005.0439.v3"},{"key":"21_CR44","doi-asserted-by":"publisher","first-page":"111544","DOI":"10.1016\/j.biopha.2021.111544","volume":"138","author":"Z Molavi","year":"2021","unstructured":"Molavi Z, Razi S, Mirmotalebisohi SA, et al (2021) Identification of FDA approved drugs against SARS-CoV-2 RNA dependent RNA polymerase (RdRp) and 3-chymotrypsin-like protease (3CLpro), drug repurposing approach. Biomed Pharmacother 138:111544. https:\/\/doi.org\/10.1016\/j.biopha.2021.111544","journal-title":"Biomed Pharmacother"},{"key":"21_CR45","doi-asserted-by":"publisher","first-page":"109851","DOI":"10.1016\/j.mehy.2020.109851","volume":"143","author":"RI Horowitz","year":"2020","unstructured":"Horowitz RI, Freeman PR (2020) Three novel prevention, diagnostic, and treatment options for COVID-19 urgently necessitating controlled randomized trials. Med Hypotheses 143:109851. https:\/\/doi.org\/10.1016\/j.mehy.2020.109851","journal-title":"Med Hypotheses"},{"issue":"11","key":"21_CR46","doi-asserted-by":"publisher","first-page":"4413","DOI":"10.1021\/acs.jpclett.0c00994","volume":"11","author":"T Huynh","year":"2020","unstructured":"Huynh T, Wang H, Luan B (2020) In silico exploration of the molecular mechanism of clinically oriented drugs for possibly inhibiting SARS-CoV-2\u2019s main protease. J Phys Chem Lett 11(11):4413\u20134420","journal-title":"J Phys Chem Lett"},{"issue":"9","key":"21_CR47","first-page":"3092","volume":"39","author":"SK Enmozhi","year":"2021","unstructured":"Enmozhi SK, Raja K, Sebastine I, et al (2021) Andrographolide as a potential inhibitor of SARS-CoV-2 main protease: an in silico approach. J Biomol Struct Dyn 39(9):3092\u20133098","journal-title":"J Biomol Struct Dyn"},{"issue":"4","key":"21_CR48","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1007\/s00203-020-02163-9","volume":"203","author":"M Kumar","year":"2021","unstructured":"Kumar M, Sodhi KK, Singh DK (2021) Addressing the potential role of curcumin in the prevention of COVID-19 by targeting the Nsp9 replicase protein through molecular docking. Arch Microbiol 203(4):1691\u20131696","journal-title":"Arch Microbiol"},{"issue":"1","key":"21_CR49","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1080\/07391102.2020.1811773","volume":"40","author":"V Chandel","year":"2022","unstructured":"Chandel V, Sharma PP, Raj S, et al (2022) Structure-based drug repurposing for targeting Nsp9 replicase and spike proteins of severe acute respiratory syndrome coronavirus 2 J Biomol Struct Dyn 40(1):249\u2013262","journal-title":"J Biomol Struct Dyn"},{"issue":"22","key":"21_CR50","doi-asserted-by":"publisher","first-page":"6900","DOI":"10.3390\/molecules26226900","volume":"26","author":"D Mar\u00edn-Palma","year":"2021","unstructured":"Mar\u00edn-Palma D, Tabares-Guevara JH, Zapata-Cardona MI, et al (2021) Curcumin inhibits in vitro SARS-CoV-2 infection in vero E6 cells through multiple antiviral mechanisms. Molecules 26(22):6900. https:\/\/doi.org\/10.3390\/molecules26226900","journal-title":"Molecules"},{"key":"21_CR51","doi-asserted-by":"publisher","unstructured":"Velazquez-Salinas L, Verdugo-Rodriguez A, Rodriguez LL, et al (2019) The role of interleukin 6 during viral infections. Front Microbiol 101057. https:\/\/doi.org\/10.3389\/fmicb.2019.01057","DOI":"10.3389\/fmicb.2019.01057"},{"issue":"1","key":"21_CR52","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/jmv.26232","volume":"93","author":"B Hu","year":"2021","unstructured":"Hu B, Huang S,Yin L (2021) The cytokine storm and COVID-19. J Med Virol 93(1):250\u2013256","journal-title":"J Med Virol"},{"issue":"6","key":"21_CR53","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20200678","volume":"217","author":"SA Vardhana","year":"2020","unstructured":"Vardhana SA, Wolchok JD (2020) The many faces of the anti-COVID immune response. J Exp Med 217(6):e20200678. https:\/\/doi.org\/10.1084\/jem.20200678","journal-title":"J Exp Med"},{"issue":"5","key":"21_CR54","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.immuni.2020.04.003","volume":"52","author":"T Hirano","year":"2020","unstructured":"Hirano T, Murakami M (2020) COVID-19: a new virus, but a familiar receptor and cytokine release syndrome. Immunity 52(5):731\u2013733","journal-title":"Immunity"},{"issue":"5","key":"21_CR55","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/irv.12459","volume":"11","author":"Y Xu","year":"2017","unstructured":"Xu Y, Liu L (2017) Curcumin alleviates macrophage activation and lung inflammation induced by influenza virus infection through inhibiting the NF-\u03baB signaling pathway. Influenza Other Respir Viruses 11(5):457\u2013463","journal-title":"Influenza Other Respir Viruses"},{"issue":"9","key":"21_CR56","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1080\/17425255.2019.1650914","volume":"15","author":"AB Kunnumakkara","year":"2019","unstructured":"Kunnumakkara AB,Harsha C,Banik K et al (2019) Is curcumin bioavailability a problem in humans: Lessons from clinical trials. Expert Opin Drug Metab Toxicol 15(9):705\u2013733","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"21_CR57","doi-asserted-by":"publisher","unstructured":"Valizadeh H,Abdolmohammadi-Vahid S,Danshina S et al (2020) Nano-curcumin therapy, a promising method in modulating inflammatory cytokines in COVID-19 patients. Int Immunopharmacol 89107088 https:\/\/doi.org\/10.1016\/j.intimp.2020.107088","DOI":"10.1016\/j.intimp.2020.107088"},{"issue":"2","key":"21_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2021.e06350","volume":"7","author":"RK Thimmulappa","year":"2021","unstructured":"Thimmulappa RK, Mudnakudu-Nagaraju KK, Shivamallu C, et al (2021) Antiviral and immunomodulatory activity of curcumin: A case for prophylactic therapy for COVID-19. Heliyon 7(2):e06350. https:\/\/doi.org\/10.1016\/j.heliyon.2021.e06350","journal-title":"Heliyon"},{"issue":"11","key":"21_CR59","doi-asserted-by":"publisher","first-page":"6417","DOI":"10.1002\/ptr.7294","volume":"35","author":"M Hassaniazad","year":"2021","unstructured":"Hassaniazad M, Eftekhar E, Inchehsablagh BR, et al (2021) A triple-blind, placebo-controlled, randomized clinical trial to evaluate the effect of curcumin-containing nanomicelles on cellular immune responses subtypes and clinical outcome in COVID-19 patients. Phytother Res 35(11):6417\u20136427","journal-title":"Phytother Res"},{"issue":"8","key":"21_CR60","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1016\/j.bbamcr.2013.04.002","volume":"1833","author":"J Zhu","year":"2013","unstructured":"Zhu J, Bultynck G, Luyten T, et al (2013) Curcumin affects proprotein convertase activity: Elucidation of the molecular and subcellular mechanism. Biochimica Biophys Acta (BBA)-Mole Cell Res 1833(8):1924\u20131935","journal-title":"Biochimica Biophys Acta (BBA)-Mole Cell Res"},{"issue":"8","key":"21_CR61","doi-asserted-by":"publisher","first-page":"3003","DOI":"10.3390\/ijms21083003","volume":"21","author":"D D\u2019ardes","year":"2020","unstructured":"D\u2019ardes D, Boccatonda A, Rossi I, et al (2020) COVID-19 and RAS: unravelling an unclear relationship. Int J Mol Sci 21(8):3003. https:\/\/doi.org\/10.3390\/ijms21083003","journal-title":"Int J Mol Sci"},{"key":"21_CR62","first-page":"6043","volume":"9","author":"XF Pang","year":"2015","unstructured":"Pang XF, Zhang LH, Bai F, et al (2015) Attenuation of myocardial fibrosis with curcumin is mediated by modulating expression of angiotensin II AT1\/AT2 receptors and ACE2 in rats. Drug Des Devel Ther 9:6043\u20136054","journal-title":"Drug Des Devel Ther"},{"issue":"supplement","key":"21_CR63","doi-asserted-by":"publisher","first-page":"69","DOI":"10.37185\/LnS.1.1.137","volume":"1","author":"F Subhan","year":"2020","unstructured":"Subhan F, Khalil AAK, Zeeshan M, et al (2020) Curcumin: from ancient spice to modern anti-viral drug in COVID-19 pandemic. Life and Science 1(supplement):69\u201373. https:\/\/doi.org\/10.37185\/LnS.1.1.137","journal-title":"Life and Science"},{"key":"21_CR64","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.jff.2015.06.011","volume":"17","author":"AJ Akinyemi","year":"2015","unstructured":"Akinyemi AJ, Thome GR, Morsch VM, et al (2015) Effect of dietary supplementation of ginger and turmeric rhizomes on angiotensin-1 converting enzyme (ACE) and arginase activities in L-NAME induced hypertensive rats. J Funct Foods 17:792\u2013801","journal-title":"J Funct Foods"},{"issue":"1","key":"21_CR65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-016-0001-8","volume":"6","author":"Y Yao","year":"2016","unstructured":"Yao Y, Wang W, Li M, et al (2016) Curcumin exerts its anti-hypertensive effect by down-regulating the AT1 receptor in vascular smooth muscle cells. Sci Rep 6(1):1\u20138","journal-title":"Sci Rep"},{"key":"21_CR66","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/978-1-0716-2395-4_4","volume":"2511","author":"SF Hawkins","year":"2022","unstructured":"Hawkins SF, Guest PC (2022) Multiplex Quantitative Polymerase Chain Reaction Diagnostic Test for SARS-CoV-2 and Influenza A\/B Viruses. Methods Mol Biol 2511:53\u201365","journal-title":"Methods Mol Biol"},{"issue":"7","key":"21_CR67","doi-asserted-by":"publisher","first-page":"5325","DOI":"10.1002\/jcp.30233","volume":"236","author":"S Tahmasebi","year":"2021","unstructured":"Tahmasebi S,El-Esawi MA,Mahmoud ZH et al (2021) Immunomodulatory effects of Nanocurcumin on Th17 cell responses in mild and severe COVID-19 patients. J Cell Physiol 236(7):5325\u20135338","journal-title":"J Cell Physiol"},{"issue":"2","key":"21_CR68","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1002\/ptr.7375","volume":"36","author":"A Asadirad","year":"2022","unstructured":"Asadirad A, Nashibi R, Khodadadi A, et al (2022) Antiinflammatory potential of nano-curcumin as an alternative therapeutic agent for the treatment of mild-to-moderate hospitalized COVID-19 patients in a placebo-controlled clinical trial. Phytother Res 36(2):1023\u20131031","journal-title":"Phytother Res"},{"key":"21_CR69","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/978-1-0716-2395-4_18","volume":"2511","author":"PC Guest","year":"2022","unstructured":"Guest PC, Abbasifard M, Jamialahmadi T, et al (2022) Multiplex Immunoassay for Prediction of Disease Severity Associated with the Cytokine Storm in COVID-19 Cases. Methods Mol Biol 2511:245\u2013256","journal-title":"Methods Mol Biol"},{"key":"21_CR70","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/978-1-0716-2395-4_21","volume":"2511","author":"F Zahedipour","year":"2022","unstructured":"Zahedipour F, Guest PC, Majeed M, et al (2022) Evaluating the Effects of Curcumin on the Cytokine Storm in COVID-19 Using a Chip-Based Multiplex Analysis. Methods Mol Biol 2511:285\u2013295","journal-title":"Methods Mol Biol"},{"key":"21_CR71","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/978-1-0716-2395-4_26","volume":"2511","author":"PC Guest","year":"2022","unstructured":"Guest PC, Rahmoune H (2022) Point-of-Care Device for Assessment of Blood Coagulation Status in COVID-19 Patients. Methods Mol Biol 2511:345\u2013354","journal-title":"Methods Mol Biol"},{"key":"21_CR72","doi-asserted-by":"publisher","unstructured":"Pawar KS, Mastud RN, Pawar SK, et al (2021) Oral curcumin with piperine as adjuvant therapy for the treatment of COVID-19: a randomized clinical trial. Front Pharmacol 1056. https:\/\/doi.org\/10.3389\/fphar.2021.669362","DOI":"10.3389\/fphar.2021.669362"},{"issue":"1","key":"21_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13063-022-06375-w","volume":"23","author":"G Askari","year":"2022","unstructured":"Askari G, Sahebkar A, Soleimani D, et al (2022) The efficacy of curcumin-piperine co-supplementation on clinical symptoms, duration, severity, and inflammatory factors in COVID-19 outpatients: a randomized double-blind, placebo-controlled trial. Trials 23(1):1\u201310","journal-title":"Trials"}],"container-title":["Advances in Experimental Medicine and Biology","Application of Omic Techniques to Identify New Biomarkers and Drug Targets for COVID-19"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-031-28012-2_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T12:06:24Z","timestamp":1687953984000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-031-28012-2_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9783031280115","9783031280122"],"references-count":73,"URL":"https:\/\/doi.org\/10.1007\/978-3-031-28012-2_21","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"29 June 2023","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}